PGHL.NS · Procter & Gamble Health Limited
India · RS rating 36 · As of 2026-10-14
| Price | 5,232.50 INR |
|---|---|
| 1-day change | -1.2% |
| RS rating (overall / 1M / 3M / 12M) | 36 / 52 / 8 / 51 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 28 / 26 / 34 |
| Industry group (rank) | Pharma (32) |
| EPS growth Q/Q | +1.6% |
| Sales growth Q/Q | -1.8% |
| Distance from 52-week high | +24.4% |
| Market cap (USD) | $908.1M |